Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidates

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2W2ehgS
via IFTTT